Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Pediatr Pulmonol. 2021 Mar 13;56(6):1617–1625. doi: 10.1002/ppul.25332

Table 2.

Variation Infants/Children with Severe BPD versus Non-Severe BPD

(Mean ± S.D. or % yes)
[Range]
Severe BPD ≤2 years of age
(n = 162)
Non-Severe BPD ≤2 years of age
(n = 84)
P Value*
Age at ascertainment (years) 0.8 ± 0.5
[0.2, 2.0]
0.7 ± 0.5
[0.2, 2.0]
0.13
Living with Smokers 10.5% 10.7% 0.92
Public Insurance 45.8%
(n = 155)
42.1%
(n = 76)
0.81
Attends Daycare 22.8% 19.2%
(n = 78)
0.74
Any Home Respiratory Support 54.3% 40.5% 0.40
Any Home Positive Pressure Ventilation
(Ventilator or CPAP/BiPAP)
16.1% 1.2% 0.001
Any Diuretics 44.4% 16.7% <0.001
Any Inhaled Steroids 56.2% 27.4% 0.010
Any Pulmonary Vasodilator
Medications
13.6% 1.2% 0.028
Any Feeding Tube 46.3% 16.7% <0.001
Sick Office or Urgent Care Visits** 19.4%
(n = 160)
18.4%
(n = 76)
0.88
Emergency Department Visits** 19.5%
(n = 159)
19.5%
(n = 77)
0.74
Hospital Admissions** 15.8%
(n = 158)
12.8%
(n = 78)
0.69
Courses of Systemic Steroids** 15.7%
(n = 153)
9.2%
(n = 76)
0.27
*

P values were generated through logistic regression clustered by center and adjusted for age at which clinical features were ascertained. The p value for age of ascertainment was generated via t test.

**

Since NICU discharge or last clinic visit.